{
    "id": "347d03ff-ed75-e982-e063-6394a90a88fa",
    "indications": "herpes zoster infections : acyclovir tablets , usp indicated acute treatment herpes zoster ( shingles ) . genital herpes : acyclovir tablets , usp indicated treatment initial episodes management recurrent episodes genital herpes . chickenpox : acyclovir tablets , usp indicated treatment chickenpox ( varicella ) .",
    "contraindications": "acute treatment herpes zoster : 800 mg every 4 hours orally , 5 times daily 7 10 days . genital herpes : treatment initial genital herpes : 200 mg every 4 hours , 5 times daily 10 days . chronic suppressive therapy recurrent disease : 400 mg 2 times daily 12 months , followed re-evaluation . alternative regimens included doses ranging 200 mg 3 times daily 200 mg 5 times daily . frequency severity episodes untreated genital herpes may change time . 1 year therapy , frequency severity patient 's genital herpes infection re-evaluated assess need continuation therapy acyclovir . intermittent therapy : 200 mg every 4 hours , 5 times daily 5 days . therapy initiated earliest sign symptom ( prodrome ) recurrence . treatment chickenpox : children ( 2 years age older ) : 20 mg/kg per dose orally 4 times daily ( 80 mg/kg/day ) 5 days . children 40 kg receive adult dose chickenpox . adults children 40 kg : 800 mg 4 times daily 5 days . intravenous acyclovir indicated treatment varicella-zoster infections immunocompromised patients . therapy indicated , initiated earliest sign symptom chickenpox . information efficacy therapy initiated 24 hours onset signs symptoms . patients acute chronic renal impairment : patients renal impairment , dose acyclovir tablets modified shown table 3. table 3. modification renal impairment normal regimen creatinine clearance ( ml/min/1.73 2 ) adjusted regimen dose ( mg ) dosing interval 200 mg every 4 hours > 10 0-10 200 200 every 4 hours , 5x daily every 12 hours 400 mg every 12 hours > 10 0-10 400 200 every 12 hours every 12 hours 800 mg every 4 hours > 25 10-25 0-10 800 800 800 every 4 hours , 5x daily every 8 hours every 12 hours hemodialysis : patients require hemodialysis , mean plasma half-life acyclovir hemodialysis approximately 5 hours . results 60 % decrease plasma concentrations following 6-hour dialysis period . therefore , patient 's dosing schedule adjusted additional dose administered dialysis . peritoneal dialysis : supplemental dose appears necessary adjustment dosing interval . bioequivalence forms : acyclovir suspension shown bioequivalent acyclovir capsules ( n = 20 ) one acyclovir 800-mg tablet shown bioequivalent four acyclovir 200-mg capsules ( n = 24 ) .",
    "warningsAndPrecautions": "acyclovir tablets , usp available : 400 mg unit dose packages 100 ( 10 x 10 ) ndc 60687-856-01 round tablet white off-white debossed hp 227 one side plain side . store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] protect light moisture . 800 mg unit dose packages 100 ( 10 x 10 ) ndc 60687-867-01 oval tablet white off-white debossed hp 228 one side plain side . store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] protect light moisture . protection : blister torn broken . packaging information american health packaging unit dose blisters ( supplied section ) contain product avet pharmaceuticals inc. follows : ( 400 mg / 100 ud ) ndc 60687-856-01 packaged ndc 23155-227 ( 800 mg / 100 ud ) ndc 60687-867-01 packaged ndc 23155-228 distributed : american health packaging columbus , oh 43217 8485601/0724",
    "adverseReactions": "acyclovir contraindicated patients develop hypersensitivity acyclovir valacyclovir .",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "POVIDONE K25",
            "code": "K0KQV10C35"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "ACYCLOVIR",
            "code": "X4HES1O11F"
        }
    ],
    "organization": "American Health Packaging",
    "name": "ACYCLOVIR",
    "effectiveTime": "20250506",
    "indications_original": "Herpes Zoster Infections: Acyclovir tablets, USP are indicated for the acute treatment of herpes zoster (shingles).\n \n                  \n                     Genital Herpes: Acyclovir tablets, USP are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes.\n \n                  \n                     Chickenpox: Acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella).",
    "contraindications_original": "Acute Treatment of Herpes Zoster: 800 mg every 4 hours orally, 5 times daily for 7 to 10 days.\n \n                  \n                     Genital Herpes:\n   \n                        Treatment of Initial Genital Herpes:\n                     200 mg every 4 hours, 5 times daily for 10 days.\n \n                  \n                     \n                        Chronic Suppressive Therapy for Recurrent Disease:\n                     400 mg 2 times daily for up to 12 months, followed by re-evaluation. Alternative regimens have included doses ranging from 200 mg 3 times daily to 200 mg 5 times daily. The frequency and severity of episodes of untreated genital herpes may change over time. After 1 year of therapy, the frequency and severity of the patient's genital herpes infection should be re-evaluated to assess the need for continuation of therapy with acyclovir.\n \n                  \n                     \n                        Intermittent Therapy:\n                     200 mg every 4 hours, 5 times daily for 5 days. Therapy should be initiated at the earliest sign or symptom (prodrome) of recurrence.\n \n                  \n                     Treatment of Chickenpox:\n   \n                        Children (2 years of age and older):\n                     20 mg/kg \n  per dose orally 4 times daily (80 mg/kg/day) for 5 days. Children over 40 kg should receive the adult dose for chickenpox.\n \n                  \n                     \n                        Adults and Children over 40 kg:\n                     800 mg 4 times daily for 5 days.\n \n                  Intravenous acyclovir is indicated for the treatment of varicella-zoster infections in immunocompromised patients. When therapy is indicated, it should be initiated at the earliest sign or symptom of chickenpox. There is no information about the efficacy of therapy initiated more than 24 hours after onset of signs and symptoms.\n                  \n                     Patients With Acute or Chronic Renal Impairment:\n                     \nIn patients with renal impairment, the dose of acyclovir tablets should be modified as shown in Table 3.\n \n                  \n                     Table 3. Dosage Modification for Renal Impairment\n                     \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \n                              \n                                 Normal Dosage\n                              \n                              \n                                 Regimen\n                              \n                           \n                           \n                              \n                                 Creatinine\n                              \n                              \n                                 Clearance\n                              \n                              \n                                 (mL/min/1.73 m\n       2) \n      \n                              \n                           \n                           \n                              \n                                 Adjusted Dosage Regimen\n                              \n                           \n                        \n                        \n                           \n                              \n                                 Dose (mg)\n                              \n                           \n                           \n                              \n                                 Dosing Interval\n                              \n                           \n                        \n                        \n                           \n                              200 mg every 4 hours\n                           \n                           \n                              >10\n                              0-10\n                           \n                           \n                              200\n                              200\n                           \n                           \n                              every 4 hours, 5x daily\n                              every 12 hours\n                           \n                        \n                        \n                           \n                              400 mg every 12 hours\n                           \n                           \n                              >10\n                              0-10\n                           \n                           \n                              400\n                              200\n                           \n                           \n                              every 12 hours\n                              every 12 hours\n                           \n                        \n                        \n                           \n                              800 mg every 4 hours\n                           \n                           \n                              >25\n                              10-25\n                              0-10\n                           \n                           \n                              800\n                              800\n                              800\n                           \n                           \n                              every 4 hours, 5x daily\n                              every 8 hours\n                              every 12 hours\n                           \n                        \n                     \n                  \n                  \n                     Hemodialysis:\n                     \nFor patients who require hemodialysis, the mean plasma half-life of acyclovir during hemodialysis is approximately 5 hours. This results in a 60% decrease in plasma concentrations following a 6-hour dialysis period. Therefore, the patient's dosing schedule should be adjusted so that an additional dose is administered after each dialysis.\n \n                  \n                     Peritoneal Dialysis:\n                     \nNo supplemental dose appears to be necessary after adjustment of the dosing interval.\n \n                  \n                     Bioequivalence of Dosage Forms:\n                     \nAcyclovir suspension was shown to be bioequivalent to acyclovir capsules (n = 20) and one acyclovir 800-mg tablet was shown to be bioequivalent to four acyclovir 200-mg capsules (n = 24).",
    "warningsAndPrecautions_original": "Acyclovir Tablets, USP are available as:\n                  \n                     400 mg Unit dose packages of 100 (10 x 10) NDC 60687-856-01\n  \nEach round tablet is white to off-white and debossed with HP 227 on one side and plain on the other side.\n \n                  \n                     Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protect from light and moisture.\n                  \n                  \n                     800 mg Unit dose packages of 100 (10 x 10) NDC 60687-867-01\n  \nEach oval tablet is white to off-white and debossed with HP 228 on one side and plain on the other side.\n \n                  \n                     Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protect from light and moisture.\n                  \n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.\n \n                  \n                     PACKAGING INFORMATION \n                     \nAmerican Health Packaging unit dose blisters (see How Supplied section) contain drug product from Avet Pharmaceuticals Inc. as follows: \n  \n                     \n(400 mg / 100 UD) NDC 60687-856-01 packaged from NDC 23155-227 \n  \n                     \n(800 mg / 100 UD) NDC 60687-867-01 packaged from NDC 23155-228\n \n                  Distributed by:\n  \nAmerican Health Packaging\n  \nColumbus, OH 43217\n \n                  8485601/0724",
    "adverseReactions_original": "Acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir."
}